Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Gavo-cel (TC-210), a mesothelin-targeted therapy, in patients with advanced mesothelin-expressing cancer…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
Clinical trial update for cemiplimab in combination with platinum-doublet chemotherapy as first-line treatment for advanced non-small cell l…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer [Phase 1]
Phase 1 clinical trial update for YL202 in patients with non-small cell lung cancer and breast cancer; the study is currently active but not…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009) [NA]
This clinical trial entry describes a study evaluating sentinel lymph node dissection (SLND) versus no SLND in cT1 invasive lung adenocarcin…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Iparomlimab and Tuvonralimab Plus Chemotherapy for Inducing Conversion to Resectability in Initially Unresectable Stage III NSCLC [Phase 2]
A Phase 2 trial evaluating the combination of iparomlimab and tuvonralimab with chemotherapy to convert initially unresectable Stage III non…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC [Phase 2]
Phase 2 study evaluating CAN-2409 plus a prodrug with standard immune checkpoint inhibitor therapy for stage III/IV non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating metabolic biomarkers to predict response to neoadjuvant immunotherapy in Non-Small Cell Lung Cancer; study statu…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Guardant Health's ORACLE trial is currently recruiting to evaluate residual cancer using a liquid biopsy across multiple cancer types.
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for BL-M09D1 in patients with locally advanced or metastatic non-small cell lung cancer and other so…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
The SIBYL study investigates therapy response assessment using liquid biopsy in cancer patients. The trial is currently recruiting and inclu…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Primary Radiotherapy In MEtastatic Lung Cancer [Phase 3]
Phase 3 clinical trial evaluating primary radiotherapy for metastatic non-small cell lung cancer; trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) [Phase 2]
A Phase 2 trial is evaluating the cancer vaccine BNT116 in combination with cemiplimab for adults with advanced non-small cell lung cancer; …
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC [Phase 2]
Phase 2 clinical trial update evaluating QL1706 with bevacizumab, with or without chemotherapy, in patients with non-squamous non-small cell…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection
This clinical trial is recruiting real-world patients with non-small cell lung cancer to evaluate neoadjuvant chemo-immunotherapy in individ…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade [Phase 2]
Phase 2 clinical trial evaluating anti-PD-1/PD-L1 antibodies in combination with bevacizumab and metronomic cyclophosphamide in patients wit…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Iparomlimab and Tuvonralimab Combined With 2 or 4 Cycles of Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC [Phase 2]
Phase 2 clinical trial evaluating iparomlimab and tuvonralimab in combination with 2 or 4 cycles of chemotherapy as neoadjuvant therapy for …
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer [Phase 1]
The document describes a Phase 1 clinical trial of aumolertinib in European participants with non-small cell lung cancer, currently recruiti…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update on cabozantinib alone or with atezolizumab for locally advanced or metastatic solid tumors; the study lists mu…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This is an update announcing a Phase II clinical study evaluating HLX43 in adults with advanced non-small cell lung cancer, currently recrui…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Combination Study of Guadecitabine/ASTX727 and Pembrolizumab [Phase 1]
A Phase 1 trial evaluating the safety of combining guadecitabine and ASTX727 with pembrolizumab in non-small cell lung cancer, currently rec…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors [Phase 2]
A Phase 2 study of IBI363 in combination therapy for advanced solid tumors, including EGFR-mutant non-small cell lung cancer and platinum-re…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Resistance to the Tyrosine Kinase Inhibitor Osimertinib and Pharmacokinetics in Non-small Cell Lung Cancer
This clinical trial update investigates resistance to the EGFR inhibitor osimertinib and its pharmacokinetics in non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Pan-tumor MRD Study
Paradigm Health's Pan-tumor MRD study (NCT06605404) is currently recruiting across several solid tumor indications including bladder, esopha…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer
This study retrospectively analyzes patients with SMARCA4-deficient tumors, including advanced non-small cell lung cancer, to describe clini…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer [NA]
An update on the CT-STAR radiotherapy approach (Computed Tomography-Guided Stereotactic Adaptive Radiotherapy) being studied for central and…